Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 1, 2020

Genentech gets FDA approval for Tecentriq, Avastin combo for HCC

Genentech has secured approval from the US Food and Drug Administration (FDA) for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) for the treatment of unresectable or metastatic hepatocellular carcinoma (HCC).

Continue
Genentech announces FDA approval for its Tecentriq, Avastin combination for unresectable or metastatic HCC. (Credit: F. Hoffmann-La Roche Ltd)
May 29, 2020

Roche to begin Covid-19 pneumonia trial with Actemra/RoActemra plus remdesivir

Roche is set to begin Covid-19 pneumonia trial with Actemra/RoActemra plus remdesivir. (Credit: Gerd Altmann from Pixabay)
May 28, 2020

Gilead signs $1.97bn worth collaboration deal with Arcus Biosciences

Gilead Sciences and Arcus Biosciences sign $1.97bn worth immuno-oncology deal. (Credit: 272447 from Pixabay)

Contracts

May 15, 2020

Takeda gets expanded EC approval for lymphoma drug Adcetris

The head office of Takeda Pharmaceutical Company, in Chuo-ku, Osaka, Japan. (Courtesy of J o / Wikimedia Commons)

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

Deals

Deals May 27, 2020

Merck to acquire Austrian vaccine maker Themis Bioscience

Pharmaceutical Business Review

Shionogi to buy Tetra Therapeutics in $500m deal

Alexion to buy biopharmaceutical firm Portola in $1.41bn deal

Affinia secures $1.6bn worth deal from Vertex to develop AAV capsids for genetic therapies

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales
7P Solutions Hires Senior Level New Business Development Executive to Help Manage Growth and Additional Sales
Vetter wins Axia Best Managed Companies Award
Vetter wins Axia Best Managed Companies Award
Softigel by Procaps – Postponed Shows
Softigel by Procaps – Postponed Shows
NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training
NSF Now Offering Live Instructor-Led Virtual Pharmaceutical and Medical Devices Training
Softigel by Procaps statement on COVID-19
Softigel by Procaps statement on COVID-19

Suppliers

Whitepapers

ISM Sensors for M800 and M300 Transmitters
ISM Sensors for M800 and M300 Transmitters
Fluorosulfates and Sulfamoyl Fluorides for Drug Design
Fluorosulfates and Sulfamoyl Fluorides for Drug Design
InPro 7100 Series
InPro 7100 Series